A systems biology network model for genetic association studies of nicotine addiction and treatment

Objective Interpreting genome-scale genetic association data, particularly for complex diseases and phenotypes, requires extensive use of prior knowledge across a broad range of potential biological and environmental influences, spanning many scientific subdisciplines. We suggest that known or hypothesized disease risk factors, and causal mechanisms, can be represented using an ontology, a computational specification of a set of concepts and the relations between them. Methods We have integrated the expertise of multiple investigators in nicotine pharmacokinetics and pharmacodynamics, nicotine dependence, and clinical smoking cessation outcomes, and represented this knowledge in an ontology-based network model. Our model spans multiple scales, from molecules, genes and cellular pathways, to complex behavioral phenotypes and even environmental factors. To leverage previous and ongoing work in the field of ontology development, we adopt, expand upon and relate elements from existing ontologies whenever possible. Results We discuss several applications of our ontology: to support interdisciplinary research by graphically representing a complex scientific theory, to facilitate meta-analysis across different studies, to highlight potential interactions, and to support statistical analysis and causal modeling. We demonstrate that our ontology can focus hypothesis testing on areas supported by current theory. Conclusion We describe how an ontology-based computational representation can be applied to disease risk factors and mechanisms, enabling the use of prior knowledge in large-scale genetic association studies in general. In specific, we have developed an initial Smoking Behavior Risk Ontology to support studies related to the pharmacogenetics of nicotine addiction and treatment.

[1]  R. Williamson.  The molecular genetics of complex inherited diseases. , 1988, The British journal of cancer. Supplement.

[2]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[3]  J. Robins,et al.  G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS Patients , 1992, Epidemiology.

[4]  P Weindling,et al.  Psychiatry and the Holocaust , 1992, Psychological Medicine.

[5]  E. Bowman,et al.  Evidence suggesting the role of specific genetic factors in cigarette smoking. , 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[6]  J. Pearl,et al.  Causal diagrams for epidemiologic research. , 1999, Epidemiology.

[7]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[8]  S Greenland,et al.  Principles of multilevel modelling. , 2000, International journal of epidemiology.

[9]  J. Pearl.  Causality: Models, Reasoning and Inference , 2000 .

[10]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[11]  P D Karp,et al.  Pathway Databases: A Case Study in Computational Symbolic Theories , 2001, Science.

[12]  S. Richardson,et al.  Variable selection and Bayesian model averaging in case‐control studies , 2001, Statistics in medicine.

[13]  N. F. Noy,et al.  Ontology Development 101: A Guide to Creating Your First Ontology , 2001 .

[14]  S. Yamato,et al.  Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells , 2001, Neuroscience Letters.

[15]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[16]  Neil A. Ernst,et al.  Jambalaya: an interactive environment for exploring ontologies , 2002, IUI '02.

[17]  E. Perez-stable,et al.  Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. , 2002, Journal of the National Cancer Institute.

[18]  Shoshiro Okada,et al.  Characterization of functional nicotinic acetylcholine receptors involved in catecholamine release from the isolated rat adrenal gland. , 2002, European journal of pharmacology.

[19]  R. Karp,et al.  Conserved pathways within bacteria and yeast as revealed by global protein network alignment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Samson W. Tu,et al.  Protégé-2000: An Open-Source Ontology-Development and Knowledge-Acquisition Environment: AMIA 2003 Open Source Expo , 2003, AMIA.

[21]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[22]  José L. V. Mejino,et al.  A reference ontology for biomedical informatics: the Foundational Model of Anatomy , 2003, J. Biomed. Informatics.

[23]  L. Floridi.  Blackwell Guide to the Philosophy of Computing and Information , 2003 .

[24]  Mark A. Bedau,et al.  Blackwell Guide to the Philosophy of Computing and Information , 2003 .

[25]  H. Feiler,et al.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[27]  Michael E Phelps,et al.  Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.

[28]  R. Tyndale,et al.  Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.

[29]  Yukiko Matsuoka,et al.  Using process diagrams for the graphical representation of biological networks , 2005, Nature Biotechnology.

[30]  Ming D. Li,et al.  Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. , 2005, Human molecular genetics.

[31]  T. Ideker,et al.  Systematic interpretation of genetic interactions using protein networks , 2005, Nature Biotechnology.

[32]  Peter V Coveney,et al.  Modelling biological complexity: a physical scientist's perspective , 2005, Journal of The Royal Society Interface.

[33]  Barry Smith,et al.  Formal ontology for natural language processing and the integration of biomedical databases , 2006, Int. J. Medical Informatics.

[34]  Raimond L Winslow,et al.  A computational model integrating electrophysiology, contraction, and mitochondrial bioenergetics in the ventricular myocyte. , 2006, Biophysical journal.

[35]  Christina N. Lessov-Schlaggar,et al.  A genome‐wide screen for nicotine dependence susceptibility loci , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  C. Lerman,et al.  Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation , 2006, Clinical pharmacology and therapeutics.

[37]  Megan E. Piper,et al.  Assessing tobacco dependence: a guide to measure evaluation and selection. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[38]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[39]  P. Shields,et al.  Effect of team sport participation on genetic predisposition to adolescent smoking progression. , 2006, Archives of general psychiatry.

[40]  L. Epstein,et al.  Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.

[41]  Christopher G Chute,et al.  National Center for Biomedical Ontology: advancing biomedicine through structured organization of scientific knowledge. , 2006, Omics : a journal of integrative biology.

[42]  Amedeo Napoli,et al.  Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing , 2006, OTM Workshops.

[43]  Nan Guo,et al.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways , 2006, Nucleic Acids Res..

[44]  Nicolas Perry,et al.  Toward a multiscale model of antigen presentation in immunity , 2007, Immunological reviews.

[45]  M. Tsuang,et al.  Educational attainment, smoking initiation and lifetime nicotine dependence among male Vietnam-era twins , 2007, Psychological Medicine.

[46]  A. C. Collins,et al.  Association of the neuronal nicotinic receptor β2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[47]  Sander Greenland,et al.  Dissecting Effects of Complex Mixtures: Who’s Afraid of Informative Priors? , 2007, Epidemiology.

[48]  Alexander D. Diehl,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm029 Databases and ontologies Ontology development for biological systems: immunology , 2006 .

[49]  D. Allen,et al.  CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. , 2007, Archives of general psychiatry.

[50]  R B Altman,et al.  The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response , 2007, Clinical pharmacology and therapeutics.

[51]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[52]  M. Ashburner,et al.  The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.

[53]  Midori A. Harris,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm112 Databases and ontologies OBO-Edit—an ontology editor for biologists , 2007 .

[54]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[55]  D. Bertrand,et al.  Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. , 2007, Annual review of pharmacology and toxicology.

[56]  A. C. Collins,et al.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. , 2007, Biochemical pharmacology.

[57]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[58]  S. Purcell,et al.  Parental monitoring moderates the importance of genetic and environmental influences on adolescent smoking. , 2007, Journal of abnormal psychology.

[59]  John H. Gennari,et al.  Integration of Multi-Scale Biosimulation Models via Light-Weight Semantics , 2008, Pacific Symposium on Biocomputing.

[60]  D. Conti,et al.  Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.

[61]  P. Muglia,et al.  α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.

[62]  Andrea Splendiani,et al.  RDFScape: Semantic Web meets Systems Biology , 2008, BMC Bioinformatics.

[63]  L. Epstein,et al.  Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion , 2008, Clinical pharmacology and therapeutics.

[64]  Kara Dolinski,et al.  Gene Ontology annotations at SGD: new data sources and annotation methods , 2007, Nucleic Acids Res..

[65]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[66]  F. Sala,et al.  Nicotinic acetylcholine receptors of adrenal chromaffin cells , 2007, Acta physiologica.

[67]  Antti Tanskanen,et al.  Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. , 2008, Physiological genomics.

[68]  A. C. Collins,et al.  The CHRNA5/A3/B4 Gene Cluster Variability as an Important Determinant of Early Alcohol and Tobacco Initiation in Young Adults , 2008, Biological Psychiatry.

[69]  H. Wit.  Faculty Opinions recommendation of Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. , 2008 .

[70]  A. C. Collins,et al.  The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. , 2007, Human molecular genetics.

[71]  Megan E. Piper,et al.  A Candidate Gene Approach Identifies the CHRNA5-A3-B4 Region as a Risk Factor for Age-Dependent Nicotine Addiction , 2008, PLoS genetics.

[72]  Christina N. Lessov-Schlaggar,et al.  Genetics of nicotine dependence and pharmacotherapy. , 2008, Biochemical pharmacology.

[73]  Daniel L. Rubin,et al.  Biomedical ontologies: a functional perspective , 2007, Briefings Bioinform..

[74]  R. Wise.  Dopamine and reward: The anhedonia hypothesis 30 years on , 2008, Neurotoxicity Research.

[75]  Isabel R Schlaepfer,et al.  Genetic Association of the CHRNA6 and CHRNB3 Genes with Tobacco Dependence in a Nationally Representative Sample , 2009, Neuropsychopharmacology.

[76]  P. Gorwood,et al.  Genetics of dopamine receptors and drug addiction: a comprehensive review , 2009, Behavioural pharmacology.

[77]  Rachael P. Huntley,et al.  The GOA database in 2009—an integrated Gene Ontology Annotation resource , 2008, Nucleic Acids Res..

[78]  William Wheeler,et al.  Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors , 2009, PloS one.

[79]  Christina N. Lessov-Schlaggar,et al.  Dopamine genes and nicotine dependence in treatment seeking and community smokers , 2009, Neuropsychopharmacology.

[80]  N. Volkow,et al.  Treatments for nicotine addiction should be a top priority , 2009, The Lancet.